Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience.


Journal

Amyotrophic lateral sclerosis & frontotemporal degeneration
ISSN: 2167-9223
Titre abrégé: Amyotroph Lateral Scler Frontotemporal Degener
Pays: England
ID NLM: 101587185

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 15 9 2020
medline: 8 5 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

We describe the telemedicine experience of an Italian ALS tertiary Center during COVID-19 pandemic. A total of 144 visits were scheduled between 6th March and 6th April 2020. These mostly consisted of neurological or psychological visits (139, 96.5%). One hundred thirty-nine (96.5%) visits were performed as telemedicine and mostly via phone call (112, 80.6%). Three (2.1%) visits were considered as urgent and maintained as outpatient care. Additionally, patients were still able to telephone, being put through directly to their neurologists. Many requests of contact were addressed at getting information about the scheduled visits or examinations (45, 43.3%). Globally, patients and caregivers were satisfied with the telemedicine service. However, the majority (85, 65.9%) would prefer a face-to-face visit. In conclusion, telemedicine could be considered a good complement to face-to-face care, even after social restrictions have been eased.

Identifiants

pubmed: 32924624
doi: 10.1080/21678421.2020.1820043
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

308-311

Auteurs

Rosario Vasta (R)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Cristina Moglia (C)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.
Neurology 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.

Fabrizio D'Ovidio (F)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Francesca Di Pede (F)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Filippo De Mattei (F)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Sara Cabras (S)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Laura Peotta (L)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Barbara Iazzolino (B)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Silvia Giusiano (S)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Umberto Manera (U)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Francesca Palumbo (F)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Alessandro Bombaci (A)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Maria Claudia Torrieri (MC)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Antonio Ilardi (A)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Enza Mastro (E)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Martina Arcari (M)

Neurology 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.

Luca Solero (L)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Maurizio Grassano (M)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Margherita Daviddi (M)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Enrico Matteoni (E)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Paolina Salamone (P)

Neurology 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.

Giuseppe Fuda (G)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.

Antonio Canosa (A)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.
Neurology 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.

Adriano Chiò (A)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.
Neurology 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.

Andrea Calvo (A)

ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy and.
Neurology 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH